Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Onyango, Elizabeth O ^a   Ayodo, George ^b   Watsierah, Carren A ^a   Were, Tom ^c   Okumu, Wilson ^a   Anyona, Samuel B ^a   Raballah, Evans ^c   Okoth, John M ^d   Gumo, Sussy ^a   Orinda, George O ^c   Ouma, Collins ^a  

^a MASENO UNIVERSITY   (Kenya)

^b UNIVERSITY OF MINNESOTA   (United States)

^c KENYATTA UNIVERSITY   (Kenya)

^d MASINDE MULIRO UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Kenya)

Author keywords

ACT; Malarial treatment; P. falciparum

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL;

ADOLESCENT; AGE; ARTEMISININ BASED COMBINATION THERAPY; ARTICLE; CHILD; COMBINATION CHEMOTHERAPY; DEMOGRAPHY; EDUCATION; FEMALE; HEALTH CARE PERSONNEL; HOUSEHOLD; HUMAN; INCOME; INFANT; KENYA; MAJOR CLINICAL STUDY; MALARIA; MALE; MEDICAL INFORMATION; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRESCRIPTION; QUESTIONNAIRE; RURAL AREA; SCHOOL CHILD; SOCIOECONOMICS; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KENYA; MALARIA; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; RURAL POPULATION; YOUNG ADULT;

EID: 84862528758     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-143     Document Type: Article

References (39)

1. WHO WHO Global Malaria Report 2000, Geneva, Switzerland: WHO- Press, WHO.
2. WHO WHO Global Malaria Report 2008, Geneva, Switzerland: WHO-Press, WHO.
3. WHO Malaria Facts Sheet 2009, Geneva, Switzerland: WHO - Press, WHO.
4. WHO Roll Back Malaria Partnership: Africa Malaria Report, Insecticide Treated Nets 2003, Geneva, Switzerland: WHO- Press, WHO.
5. Bloland PB, Kachur SP, Williams HA. Trends in antimalarial drug deployment in sub-Saharan Africa. J Exp Biol 2003, 206(Pt 21):3761-3769.
6. Warrel D, Gilles H. Essential malariology 2002, Great Britain: Anold Publishers.
7. Ogutu BR. Malaria management-progress made and challenges still to face. Malar J 2009, 8(Suppl 1):S1. 10.1186/1475-2875-8-S1-S1, 2777322, 19917070.
8. Kokwaro G. Ongoing challenges in the management of malaria. Malar J 2009, Suppl 1:S2.
9. Bloland PB, Kazembe PN, Oloo AJ, Himonga B, Barat LM, Ruebush TK. Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Trop Med Int Health 1998, 3(7):543-552. 10.1046/j.1365-3156.1998.00270.x, 9705188.
10. Kachur SP, Khatib RA, Kaizer E, Fox SS, Abdulla SM, Bloland PB. Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am J Trop Med Hyg 2004, 71(6):715-722.
11. Kenya National Bureau of Statistics ICF Macro: Kenya Demographic Health Survey 2008-09 2010, Calverton, Maryland: KNBS and ICF Macro, Kenya National Bureau of Statistics.
12. IHRS Rational Use of Drugs: What it is and what are the prerequisite for its fulfilments?. Journal of Health 2006, 10:2-8. IHRS.
13. Ministry of Public Health and Sanitation Ministry of Medical Services: National guidelines for the diagnosis, treatment and prevention of malaria in Kenya 2010, Nairobi, Kenya: MOPHS and MOMS, 3, Ministry of Public Health and Sanitation.
14. Ministry of Health The Kenya National Drug Policy 1994, Nairobi, Kenya: Government Printers, Ministry of Health.
15. Beier JC, Oster CN, Onyango FK, Bales JD, Sherwood JA, Perkins PV, Chumo DK, Koech DV, Whitmire RE, Roberts CR, et al. Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am J Trop Med Hyg 1994, 50(5):529-536.
16. Hamel MJ, Odhacha A, Roberts JM, Deming MS. Malaria control in Bungoma District, Kenya: a survey of home treatment of children with fever, bednet use and attendance at antenatal clinics. Bull World Health Organ 2001, 79(11):1014-1023. 2566703, 11731808.
17. Central Bureau of Statistics (CBS) Kisumu District Development Plan (KDDP) 2001, 1-11. Kenya National Bureau of Statistics Publications, Central Bureau of Statistics (CBS).
18. Fisher L. Self-designing clinical trials. Statistics in Medicine 1998, 17:1551-1562. 10.1002/(SICI)1097-0258(19980730)17:14<1551::AID-SIM868>3.0.CO;2-E, 9699229.
19. Kombo KD, Tromp DL. Proposal and thesis writing: An introduction 2006, Nairobi: Paulines publication.
20. Oso YW, Onen D. A general guide to writing research proposal and report: A handbook for beginning researchers 2005, Uganda: Makerere Universirt Printery, Kampala.
21. Depoortere E, Guthmann JP, Sipilanyambe N, Nkandu E, Fermon F, Balkan S, Legros D. Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health 2004, 9(1):62-67. 10.1046/j.1365-3156.2003.01157.x, 14728608.
22. Dondorp AM, Newton PN, Mayxay M, Van Damme W, Smithuis FM, Yeung S, Petit A, Lynam AJ, Johnson A, Hien TT, et al. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health 2004, 9(12):1241-1246. 10.1111/j.1365-3156.2004.01342.x, 15598255.
23. Simsek Z, Kurcer MA. Malaria: knowledge and behaviour in an endemic rural area of Turkey. Public Health 2005, 119(3):202-208. 10.1016/j.puhe.2004.03.011, 15661131.
24. Awad AI, Eltayeb IB. Self-medication practices with antibiotics and antimalarials among Sudanese undergraduate university students. Ann Pharmacother 2007, 41(7):1249-1255. 10.1345/aph.1K068, 17565044.
25. Deressa W. Treatment-seeking behaviour for febrile illness in an area of seasonal malaria transmission in rural Ethiopia. Malar J 2007, 6:49. 10.1186/1475-2875-6-49, 1866240, 17462087.
26. Schellenberg JA, Victora CG, Mushi A, de Savigny D, Schellenberg D, Mshinda H, Bryce J. Inequities among the very poor: health care for children in rural southern Tanzania. Lancet 2003, 361(9357):561-566. 10.1016/S0140-6736(03)12515-9, 12598141.
27. Deressa W, Ali A, Enqusellassie F. Self-treatment of malaria in rural communities, Butajira, southern Ethiopia. Bull World Health Organ 2003, 81(4):261-268. 2572446, 12764492.
28. Yeung S, Van Damme W, Socheat D, White NJ, Mills A. Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J 2008, 7:96. 10.1186/1475-2875-7-96, 2430580, 18510724.
29. Chuma J, Gilson L, Molyneux C. Treatment-seeking behaviour, cost burdens and coping strategies among rural and urban households in Coastal Kenya: an equity analysis. Trop Med Int Health 2007, 12(5):673-686. 10.1111/j.1365-3156.2007.01825.x, 17445135.
30. Chuma J, Musimbi J, Okungu V, Goodman C, Molyneux C. Reducing user fees for primary health care in Kenya: Policy on paper or policy in practice?. Int J Equity Health 2009, 8:15. 10.1186/1475-9276-8-15, 2683851, 19422726.
31. Noor AM, Zurovac D, Hay SI, Ochola SA, Snow RW. Defining equity in physical access to clinical services using geographical information systems as part of malaria planning and monitoring in Kenya. Trop Med Int Health 2003, 8(10):917-926. 10.1046/j.1365-3156.2003.01112.x, 2912492, 14516303.
32. Zurovac D, Ndhlovu M, Rowe AK, Hamer DH, Thea DM, Snow RW. Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study. BMJ 2005, 331(7519):734. 10.1136/bmj.331.7519.734, 1239975, 16195289.
33. Looareesuwan S, Wilairatana P, Chokejindachai W, Chalermrut K, Wernsdorfer W, Gemperli B, Gathmann I, Royce C. A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg 1999, 60(2):238-243.
34. van Vugt M, Brockman A, Gemperli B, Luxemburger C, Gathmann I, Royce C, Slight T, Looareesuwan S, White NJ, Nosten F. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob Agents Chemother 1998, 42(1):135-139. 105468, 9449273.
35. Ashley EA, Stepniewska K, Lindegardh N, Annerberg A, Kham A, Brockman A, Singhasivanon P, White NJ, Nosten F. How much fat is necessary to optimize lumefantrine oral bioavailability?. Trop Med Int Health 2007, 12(2):195-200. 10.1111/j.1365-3156.2006.01784.x, 17300625.
36. Schoepflin S, Lin E, Kiniboro B, DaRe JT, Mehlotra RK, Zimmerman PA, Mueller I, Felger I. Treatment with coartem (artemether-lumefantrine) in Papua New Guinea. Am J Trop Med Hyg 2010, 82(4):529-534. 10.4269/ajtmh.2010.09-0334, 2844564, 20348494.
37. Alvarado BE, Alzate A, Mateus JC, Carvajal R. Effects of an educational and participatory community intervention on malaria control in Buenaventura, Colombia. Biomedica 2006, 26(3):366-378.
38. Alvarado BE, Gomez E, Serra M, Carvajal R, Carrasquilla G. Evaluation of an educational strategy on malaria in rural areas of the Colombian Pacific Coast. Biomedica 2006, 26(3):342-352.
39. Tavrow P, Shabahang J, Makama S. Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District Kenya. Malar J 2003, 2:10. 10.1186/1475-2875-2-10, 161786, 12812525.